Petros Pharmaceuticals Share Holder Equity 2013-2025 | PTPI

Petros Pharmaceuticals share holder equity from 2013 to 2025. Share holder equity can be defined as the sum of preferred and common equity items

Petros Pharmaceuticals Annual Share Holder Equity (Millions of US $)
2024	$-7
2023	$12
2022	$17
2021	$36
2020	$17
2019	$8
2018	$27
2017	$15
2016	$24
2015	$12
2014	$7
2013	$15
2012	$-1

Petros Pharmaceuticals Quarterly Share Holder Equity (Millions of US $)
2025-09-30	$3
2025-06-30	$4
2025-03-31	$-10
2024-12-31	$-7
2024-09-30	$3
2024-06-30	$8
2024-03-31	$10
2023-12-31	$12
2023-09-30	$7
2023-06-30	$13
2023-03-31	$15
2022-12-31	$17
2022-09-30	$21
2022-06-30	$34
2022-03-31	$36
2021-12-31	$36
2021-09-30	$18
2021-06-30	$19
2021-03-31	$21
2020-12-31	$17
2020-09-30	$28
2020-06-30	$30
2020-03-31	$32
2019-12-31	$8
2019-09-30	$19
2019-06-30	$21
2019-03-31	$23
2018-12-31	$27
2018-09-30	$9
2018-06-30	$12
2018-03-31	$14
2017-12-31	$15
2017-09-30	$17
2017-06-30	$19
2017-03-31	$22
2016-12-31	$24
2016-09-30	$5
2016-06-30	$8
2016-03-31	$10
2015-12-31	$12
2015-09-30	$0
2015-06-30	$2
2015-03-31	$5
2014-12-31	$7
2014-09-30	$9
2014-06-30	$12
2014-03-31	$13
2013-12-31	$15
2013-09-30	$16
2013-06-30	$0
2013-03-31	$0
2012-12-31

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$0.000B	$0.005B
Petros Pharmaceuticals Inc. is a men's health company. It engages in identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease, hormone health and substance use disorders. Petros Pharmaceuticals Inc., formerly known as Neurotrope Inc., is based in NEW YORK.

Stock Name	Country	Market Cap	PE Ratio
Chugai Pharmaceutical (CHGCY)	Japan	$92.642B	32.36
Takeda Pharmaceutical (TAK)	Japan	$56.448B	11.09
Zoetis (ZTS)	United States	$55.836B	19.98
BeOne Medicines - (ONC)	Switzerland	$38.601B	204.65
Daiichi Sankyo, - (DSNKY)	Japan	$35.368B	17.61
Sandoz Group AG (SDZNY)	Switzerland	$34.628B	0.00
United Therapeutics (UTHR)	United States	$20.779B	18.29
Merck (MKKGY)	Germany	$18.986B	11.70
Shionogi (SGIOY)	Japan	$18.324B	14.17
Ionis Pharmaceuticals (IONS)	United States	$13.766B	0.00
Neurocrine Biosciences (NBIX)	United States	$13.745B	32.98
IPSEN (IPSEY)	France	$13.548B	0.00
Orion OYJ (ORINY)	Finland	$11.502B	32.86
Summit Therapeutics (SMMT)	United States	$11.120B	0.00
Madrigal Pharmaceuticals (MDGL)	United States	$10.870B	0.00
Eisai (ESAIY)		$8.306B	0.00
Ono Pharmaceutical (OPHLF)	Japan	$7.149B	17.10
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$4.947B	0.00
Crinetics Pharmaceuticals (CRNX)	United States	$4.846B	0.00
Stevanato Group S.p.A (STVN)	Italy	$4.570B	25.58
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$4.536B	21.54
Indivior Pharmaceuticals (INDV)	United States	$4.293B	17.52
Corcept Therapeutics (CORT)	United States	$4.221B	45.60
NewAmsterdam Pharma (NAMS)	Netherlands	$3.740B	0.00
Centessa Pharmaceuticals (CNTA)	United Kingdom	$3.361B	0.00
Catalyst Pharmaceuticals (CPRX)	United States	$3.080B	9.83
Hypermarcas (HYPMY)	Brazil	$3.002B	20.61
Dyne Therapeutics (DYN)	United States	$2.604B	0.00
Soleno Therapeutics (SLNO)	United States	$2.262B	0.00
Avadel Pharmaceuticals (AVDL)	Ireland	$2.106B	0.00
Guardian Pharmacy Services (GRDN)	United States	$1.991B	38.34
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$1.922B	22.78
Ocular Therapeutix (OCUL)	United States	$1.822B	0.00
Ardelyx (ARDX)	United States	$1.793B	0.00
Harrow (HROW)	United States	$1.748B	107.27
Definium Therapeutics (DFTX)	United States	$1.678B	0.00
Enliven Therapeutics (ELVN)	United States	$1.651B	0.00
Oruka Therapeutics (ORKA)	United States	$1.598B	0.00
Amylyx Pharmaceuticals (AMLX)	United States	$1.524B	0.00
Collegium Pharmaceutical (COLL)	United States	$1.523B	7.54
Relay Therapeutics (RLAY)	United States	$1.472B	0.00
BioCryst Pharmaceuticals (BCRX)	United States	$1.353B	80.25
Evotec AG (EVO)	Germany	$1.322B	0.00
Xeris Biopharma Holdings (XERS)	United States	$1.175B	0.00
Savara (SVRA)	United States	$1.091B	0.00
Theravance Biopharma (TBPH)	United States	$1.018B	42.74
Aktis Oncology (AKTS)	United States	$1.009B	0.00
ARS Pharmaceuticals (SPRY)	United States	$1.002B	0.00
Cronos Group (CRON)	Canada	$0.985B	0.00
Xencor (XNCR)	United States	$0.823B	0.00
Esperion Therapeutics (ESPR)	United States	$0.818B	0.00
Nektar Therapeutics (NKTR)	United States	$0.766B	0.00
KalVista Pharmaceuticals (KALV)	United States	$0.757B	0.00
Ironwood Pharmaceuticals (IRWD)	United States	$0.730B	17.25
Bioventus (BVS)	United States	$0.670B	13.73
Rigel Pharmaceuticals (RIGL)	United States	$0.634B	5.66
Altimmune (ALT)	United States	$0.579B	0.00
ProKidney (PROK)	United States	$0.572B	0.00
4D Molecular Therapeutics (FDMT)	United States	$0.531B	0.00
Lexeo Therapeutics (LXEO)	United States	$0.531B	0.00
Lyell Immunopharma (LYEL)	United States	$0.514B	0.00
Zevra Therapeutics (ZVRA)	United States	$0.503B	0.00
Organogenesis (ORGO)	United States	$0.495B	0.00
Aquestive Therapeutics (AQST)	United States	$0.488B	0.00
Siga Technologies (SIGA)	United States	$0.482B	6.60
Nature's Sunshine Products (NATR)	United States	$0.453B	26.98
Elite Pharmaceuticals (ELTP)	United States	$0.423B	0.00
Aclaris Therapeutics (ACRS)	United States	$0.384B	0.00
USANA Health Sciences (USNA)	United States	$0.382B	10.66
Akebia Therapeutics (AKBA)	United States	$0.364B	0.00
Protara Therapeutics (TARA)	United States	$0.346B	0.00
Cybin (HELP)	Canada	$0.317B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.314B	0.00
Journey Medical (DERM)	United States	$0.280B	0.00
Larimar Therapeutics (LRMR)	United States	$0.272B	0.00
Relmada Therapeutics (RLMD)	United States	$0.268B	0.00
Avalo Therapeutics (AVTX)	United States	$0.266B	0.00
Enlivex Therapeutics (ENLV)	Israel	$0.261B	0.00
OmniAb (OABI)	United States	$0.250B	0.00
Profound Medical (PROF)	Canada	$0.248B	0.00
Heron Therapeutics (HRTX)	United States	$0.242B	0.00
MediWound (MDWD)	Israel	$0.226B	0.00
Achieve Life Sciences (ACHV)	Canada	$0.224B	0.00
Context Therapeutics (CNTX)	United States	$0.211B	0.00
Silence Therapeutics (SLN)	United Kingdom	$0.203B	0.00
Surrozen (SRZN)	United States	$0.203B	0.00
Minerva Neurosciences (NERV)	United States	$0.202B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.198B	0.00
Galectin Therapeutics (GALT)	United States	$0.191B	0.00
Innate Pharma SA (IPHYF)	France	$0.181B	0.00
AleAnna (ANNA)	United States	$0.171B	0.00
Century Therapeutics (IPSC)	United States	$0.156B	0.00
VAXART, INC (VXRT)	United States	$0.151B	0.00
Prelude Therapeutics (PRLD)	United States	$0.145B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.141B	0.00
Unicycive Therapeutics (UNCY)	United States	$0.140B	0.00
Avita Medical (RCEL)	United States	$0.124B	0.00
Inhibikase Therapeutics (IKT)	United States	$0.117B	0.00
Korro Bio (KRRO)	United States	$0.115B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.115B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.114B	0.00
Cardiol Therapeutics (CRDL)	Canada	$0.113B	0.00
Vivani Medical (VANI)	United States	$0.103B	0.00
Incannex Healthcare (IXHL)	Australia	$0.099B	0.00
Cassava Sciences (SAVA)	United States	$0.094B	0.00
Pyxis Oncology (PYXS)	United States	$0.094B	0.00
Champions Oncology (CSBR)	United States	$0.091B	38.71
Assertio Holdings (ASRT)	United States	$0.076B	0.00
PolyPid (PYPD)	Israel	$0.070B	0.00
HST Global (HSTC)	United States	$0.069B	0.00
Gain Therapeutics (GANX)	United States	$0.068B	0.00
Dominari Holdings (DOMH)	United States	$0.062B	0.00
Rafael Holdings (RFL)	United States	$0.062B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.059B	49.25
Fractyl Health (GUTS)	United States	$0.058B	0.00
Procaps Group, S.A (PROCF)	Luxembourg	$0.058B	0.00
BioNxt Solutions (BNXTF)	Canada	$0.055B	0.00
PMV Pharmaceuticals (PMVP)	United States	$0.055B	0.00
NRx Pharmaceuticals (NRXP)	United States	$0.054B	0.00
Acrivon Therapeutics (ACRV)	United States	$0.053B	0.00
Nutriband (NTRB)	United States	$0.053B	0.00
Lipocine (LPCN)	United States	$0.045B	0.00
ElectroCore (ECOR)	United States	$0.044B	0.00
Telomir Pharmaceuticals (TELO)	United States	$0.040B	0.00
FibroGen (FGEN)	United States	$0.039B	0.00
Lite Strategy (LITS)	United States	$0.039B	0.00
Liminatus Pharma (LIMN)	United States	$0.039B	0.00
Talphera (TLPH)	United States	$0.037B	0.00
Mural Oncology (MURA)	Ireland	$0.035B	0.00
Plus Therapeutics (PSTV)	United States	$0.034B	0.00
Reviva Pharmaceuticals Holdings (RVPH)	United States	$0.032B	0.00
SCYNEXIS (SCYX)	United States	$0.030B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.030B	0.00
Wellgistics Health (WGRX)	United States	$0.030B	0.00
TherapeuticsMD (TXMD)	United States	$0.026B	0.00
Natural Alternatives (NAII)	United States	$0.023B	0.00
VYNE Therapeutics (VYNE)	United States	$0.019B	0.00
Jupiter Neurosciences (JUNS)	United States	$0.019B	0.00
Scienture Holdings (SCNX)	United States	$0.019B	0.00
Klotho Neurosciences (KLTO)	United States	$0.019B	0.00
Cosmos Health (COSM)	United States	$0.018B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.016B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.016B	0.00
Traws Pharma (TRAW)	United States	$0.016B	0.02
Inotiv (NOTV)	United States	$0.015B	0.00
Vyome Holdings (HIND)	United States	$0.015B	0.00
Mannatech (MTEX)	United States	$0.014B	0.00
Vivos Therapeutics (VVOS)	United States	$0.014B	0.00
BioLineRx (BLRX)	Israel	$0.013B	0.00
Tempest Therapeutics (TPST)	United States	$0.012B	0.00
CASI Pharmaceuticals (CASI)	China	$0.012B	0.00
Phio Pharmaceuticals (PHIO)	United States	$0.010B	0.00
Ainos (AIMD)	United States	$0.010B	0.00
Addex Therapeutics (ADXN)	Switzerland	$0.009B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.009B	0.00
BioVie (BIVI)	United States	$0.009B	0.00
Curanex Pharmaceuticals Inc (CURX)	United States	$0.008B	0.00
Kiora Pharmaceuticals (KPRX)	United States	$0.008B	0.00
TransCode Therapeutics (RNAZ)	United States	$0.008B	0.00
Nuvilex (PMCB)	United States	$0.007B	0.00
Biomerica (BMRA)	United States	$0.007B	0.00
Ernexa Therapeutics (ERNA)	United States	$0.007B	0.00
Quoin Pharmaceuticals (QNRX)	United States	$0.006B	0.00
Mangoceuticals (MGRX)	United States	$0.006B	0.00
Alaunos Therapeutics (TCRT)	United States	$0.006B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.005B	0.00
Redhill Biopharma (RDHL)	Israel	$0.005B	0.00
Heatwurx (PCSA)	United States	$0.005B	0.00
Aptorum Group (APM)	United Kingdom	$0.005B	0.00
Xenetic Biosciences (XBIO)	United States	$0.005B	0.00
Salarius Pharmaceuticals (SLRX)	United States	$0.005B	0.00
60 Degrees Pharmaceuticals (SXTP)	United States	$0.005B	0.00
Indaptus Therapeutics (INDP)	United States	$0.004B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.004B	0.00
XORTX Therapeutics (XRTX)	Canada	$0.003B	0.00
Lyra Therapeutics (LYRA)	United States	$0.003B	0.00
InMed Pharmaceuticals (INM)	Canada	$0.003B	0.00
Clearmind Medicine (CMND)	Canada	$0.003B	0.00
Shuttle Pharmaceuticals Holdings (SHPH)	United States	$0.003B	0.00
Universe Pharmaceuticals INC (UPC)	China	$0.002B	0.00
SciSparc (SPRC)	Israel	$0.002B	0.00
Jaguar Animal Health (JAGX)	United States	$0.002B	0.00
CDT Equity (CDT)	United States	$0.002B	0.00
PainReform (PRFX)	Israel	$0.001B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.001B	0.00
Aditxt (ADTX)	United States	$0.000B	0.00
Emisphere Technologies (EMIS)	United States	$0.000B	0.00
Grifols, S.A (GRFS)	Spain	$0.000B	0.00
4D Pharma (LBPS)	United Kingdom	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00
RVL Pharmaceuticals (RVLP)	United States	$0.000B	0.00